T2 Biosystems, Inc. Net Cash Provided by (Used in) Continuing Operations
T2 Biosystems, Inc. reported Net Cash Provided by (Used in) Continuing Operations of -$31.69 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-19.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2018-03-19
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for the quarter ending 2017-12-31 was -$11.10M.
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for the quarter ending 2017-09-30 was $6.76M, a 72.83% decline year-over-year.
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for the quarter ending 2017-06-30 was -$12.69M.
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was -$14.67M.
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for fiscal 2017 was -$31.69M.
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for fiscal 2016 was -$174.00K.
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for fiscal 2015 was -$187.00K, a 100.43% decline from fiscal 2014.
- T2 Biosystems, Inc. net cash provided by (used in) continuing operations for fiscal 2014 was $43.65M, a 113.05% increase from fiscal 2013.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$11.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$4.33M derived: sum of 2 quarters · filed 2018-03-19 | -$17.02M derived: sum of 3 quarters · filed 2018-03-19 | -$31.69M 10-K · filed 2018-03-19 |
| 2017-09-30 | $6.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$5.92M derived: sum of 2 quarters · filed 2017-11-03 | -$20.59M 10-Q · filed 2017-11-03 | -$22.21M derived: sum of 4 quarters · filed 2018-03-19 |
| 2017-06-30 | -$12.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$27.35M 10-Q · filed 2017-08-04 | -$28.98M derived: sum of 3 quarters · filed 2018-03-19 | -$4.08M derived: sum of 4 quarters · filed 2018-03-19 |
| 2017-03-31 | -$14.67M 10-Q · filed 2017-05-08 | -$16.29M derived: sum of 2 quarters · filed 2018-03-19 | $8.60M derived: sum of 3 quarters · filed 2018-03-19 | -$697.00K derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $23.27M derived: sum of 2 quarters · filed 2018-03-19 | $13.97M derived: sum of 3 quarters · filed 2018-03-19 | -$174.00K 10-K · filed 2018-03-19 |
| 2016-09-30 | $24.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $15.59M derived: sum of 2 quarters · filed 2017-11-03 | $1.45M 10-Q · filed 2017-11-03 | $34.99M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-06-30 | -$9.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$23.44M 10-Q · filed 2017-08-04 | $10.10M derived: sum of 3 quarters · filed 2018-03-19 | -$3.07M derived: sum of 4 quarters · filed 2018-03-19 |
| 2016-03-31 | -$14.14M 10-Q · filed 2017-05-08 | $19.40M derived: sum of 2 quarters · filed 2018-03-19 | $6.23M derived: sum of 3 quarters · filed 2018-03-19 | -$5.78M derived: sum of 4 quarters · filed 2018-03-19 |
| 2015-12-31 | $33.55M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $20.37M derived: sum of 2 quarters · filed 2018-03-19 | $8.37M derived: sum of 3 quarters · filed 2018-03-19 | -$187.00K 10-K · filed 2018-03-19 |
| 2015-09-30 | -$13.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$25.18M derived: sum of 2 quarters · filed 2016-11-08 | -$33.73M 10-Q · filed 2016-11-08 | -$35.47M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | -$12.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$20.56M 10-Q · filed 2016-08-08 | -$22.30M derived: sum of 3 quarters · filed 2017-03-15 | $37.41M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | -$8.55M 10-Q · filed 2016-05-09 | -$10.29M derived: sum of 2 quarters · filed 2017-03-15 | $49.42M derived: sum of 3 quarters · filed 2017-03-15 | $41.60M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $57.97M derived: sum of 2 quarters · filed 2017-03-15 | $50.15M derived: sum of 3 quarters · filed 2017-03-15 | $43.65M 10-K · filed 2017-03-15 |
| 2014-09-30 | $59.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $51.89M derived: sum of 2 quarters · filed 2015-11-04 | $45.39M 10-Q · filed 2015-11-04 | $40.37M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-06-30 | -$7.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$14.32M 10-Q · filed 2015-08-05 | -$19.34M derived: sum of 3 quarters · filed 2016-03-09 | -$24.71M derived: sum of 4 quarters · filed 2016-03-09 |
| 2014-03-31 | -$6.50M 10-Q · filed 2015-05-06 | -$11.52M derived: sum of 2 quarters · filed 2016-03-09 | -$16.88M derived: sum of 3 quarters · filed 2016-03-09 | |
| 2013-12-31 | -$5.02M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | -$10.38M derived: sum of 2 quarters · filed 2016-03-09 | $20.49M 10-K · filed 2016-03-09 | |
| 2013-09-30 | -$5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $25.51M 10-Q · filed 2014-11-05 | ||
| 2013-06-30 | $30.87M 10-Q · filed 2014-09-19 | |||
| 2012-12-31 | -$9.04M 10-K · filed 2015-03-04 |